Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01582841 · ClinicalTrials.gov registry record · NA
Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
NCT01582841 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 247 participants.
The verdict
NCT01582841, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
Study Summary
The investigators research mobilizes the resources of an integrated health-delivery system with extensive electronic clinical data to implement and evaluate a new strategy to maximize screening of Colorectal Cancer (CRC) patients for Lynch Syndrome.
Interventions
- PROCEDURE MSI screening test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01582841
The ClinicalTrials.gov registry entry for NCT01582841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MSI screening test is the first listed.
NCT01582841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01582841 about?
NCT01582841 is a clinical study titled "Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting". The investigators research mobilizes the resources of an integrated health-delivery system with extensive electronic clinical data to implement and evaluate a new strategy to maximize screening of Colorectal Cancer (CRC) patients for Lynch Syndrome.
What is the current status of trial NCT01582841?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2012-02. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01582841?
The interventions under investigation include: MSI screening test (PROCEDURE).
Who is sponsoring clinical trial NCT01582841?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.